Key Takeaways
- • Wendy's said on Thursday, November 5, 2026, that an independent committee of its board unanimously rejected a $1.4 billion take-private offer led by Trian Fund Management, according to Law360.
- • The board adopted a shareholder rights plan designed to deter the Trian-led group from acquiring additional Wendy's shares without board approval.
- • The rejection follows the public disclosure of the buyout proposal the prior week, marking a formal board response to the approach.
Summary
To guard against further accumulation of its stock by the Trian-led group, the board adopted a shareholder rights plan. The plan is intended to deter the group from acquiring additional shares without the approval of the board. Shareholder rights plans, commonly called poison pills, typically make large unsolicited stake-building economically unattractive unless the board consents.
The primary source reporting is limited to the board's announcement and the rights plan. Additional details regarding the offer price per share, financing structure, or the composition of the Trian-led group were not included in the available coverage and are therefore not reported here.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.